Raymond James sets USD 95 target for RadNet stock

Published on 10/20/2026 at 19:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue reached USD 622.70 million, up 25.00 percent year over year. RadNet stock costs EUR 62.49 on October 20, 2026, up 1.24 percent on Nasdaq.

Analyst target and results

Raymond James initiated coverage with a USD 95.00 target on September 28, 2026.
Second-quarter 2026 revenue reached USD 622.70 million, up 25.00 percent year over year.
RadNet stock costs EUR 62.49 at Lang & Schwarz on October 20, 2026 at 7:15 p.m. CEST, with Nasdaq stock up 1.24 percent.
RadNet is estimated to report third-quarter 2026 results on November 9, 2026.

RDNT, US7504911022, Illustration mit AI erstellt.

RadNet (ISIN US7504911022) has a USD 95.00 price target from Raymond James, which initiated coverage with a Strong Buy rating on September 28, 2026, according to Investing.com. The target is 35.47 percent above the USD 70.13 Nasdaq price reported on October 20, 2026. At Lang & Schwarz, RadNet stock was trading at EUR 62.49 on October 20, 2026 at 7:15 p.m. CEST, while the Nasdaq quote was up 1.24 percent at USD 70.13 versus its prior close of USD 69.27.

Revenue growth remains visible

RadNet's second-quarter 2026 revenue reached USD 622.70 million, an increase of 25.00 percent from the same quarter a year earlier. The figure exceeded analyst expectations by 2.30 percent, according to Yahoo Finance.

The digital health segment grew 56.50 percent year over year in the second quarter, while RadNet's network included more than 350 imaging facilities across seven states. The combination gives the analyst target a concrete operating reference, although the company still depends on reimbursement and execution in a competitive diagnostic imaging market.

Price position and valuation

RadNet's Nasdaq price of USD 70.13 on October 20, 2026 stood within its 52-week range of USD 50.82 to USD 85.84. The current level was 18.30 percent below the 52-week high, based on the range reported by MarketBeat.

Next report date is November 9

RadNet is estimated to report third-quarter 2026 results on November 9, 2026, with consensus revenue of USD 639.97 million and consensus earnings per share of USD 0.2214, according to MarketBeat. The estimate compares with USD 522.87 million revenue and USD 0.20 earnings per share in the third quarter of 2025.

Peer comparison

Quest Diagnostics (NYSE, USD): up 0.60 percent, price-to-earnings ratio 25.09, market capitalization USD 26.1 billion. The comparison highlights RadNet's smaller USD 5.5 billion market value and its stronger recent revenue growth, but the businesses differ in their mix of imaging and laboratory services.

Trading level and outlook

RadNet's market capitalization was USD 5.5 billion on October 20, 2026. Its next scheduled reporting date gives investors a defined near-term event, while the USD 95.00 Raymond James target remains the clearest external valuation reference in the latest coverage.

RadNet was trading at EUR 62.49 at Lang & Schwarz on October 20, 2026 at 7:15 p.m. CEST. The Nasdaq quote was up 1.24 percent versus the prior close of October 19, 2026, with the stock at USD 70.13. The further course of trading is shown by the continuously updated real-time quote of RadNet stock.